Frequencies of CYP1A2 Single Nucleotide Polymorphism in Indonesian and Its Effect on Blood Pressure

Erizal Sugiono, Andi Wijaya, Anwar Santoso, Ferry Sandra, Ilham Jaya Patellongi, Irawan Yusuf

Abstract


BACKGROUND:  The association between caffeine with blood pressure (BP) still remains controversial. Caffeine is mainly metabolized by cytochrome-P450 (CYP)1A2 enzyme. Polymorphism of CYP1A2 is known to cause interindividual variation on enzymatic activity, thus affects caffeine metabolism and its effect on cardiovascular (CV) system.

METHODS: We conducted a cross-sectional study and recruited 121 Indonesian subjects aged 25-60 years with varying coffee-drinking habits. DNA was extracted from peripheral blood and genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCRRFLP) technique. Blood pressures were measured in the morning prior to the daily activity. Caffeine concentration in blood plasma was measured using high-performance liquid chromatography (HPLC). The differences between variables were analyzed using MannWhitney analysis and the correlations among variables were determined using multivariate logistic regression analysis.

RESULTS: This study showed that the frequencies of single nucleotide polymorphisms (SNPs) among Indonesian were 31.8%, 18.2%, 25.2% and 24.8% respectively for CYP1A2*1A, CYP1A2*1B, CYP1A2*1C and CYP1A2*1F alleles. The genotype analysis showed that the subject number of the wild type (*1A/*1A) and the variants were 9.92% and 90.08%. There were no significant differences in term of BP levels among CYP1A2 genotypes and coffee drinking habit groups.

CONCLUSIONS: The frequencies of CYP1A2 SNPs in Indonesian are different with frequencies in other populations. Since the association were not statistically significant, CYP1A2 polymorphisms as the predictor of elevated blood pressuare should be investigated further.

KEYWORDS: coffee, caffeine, blood pressure, single nucleotide polymorphism, CYP1A2

Full Text:

PDF

References


Cornelis MC, El-Sohemy A. Coffee, caffeine, and coronary heart disease. Curr Opin Lipidol. 2007; 18: 13-9, CrossRef.

James JE. Critical review of dietary caffeine and blood pressure: a relationship that should be taken more seriously. Psychosom Med. 2001; 66: 63-71, CrossRef.

Hamer M. Coffee and health: explaining conflicting results in hypertension. J Hum Hypertens. 2006; 20: 909-12, CrossRef.

Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H. Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA. 2006; 295: 1135-41, CrossRef.

Soyama A, Saito Y, Hanioka N, Maekawa K, Komamura K, Kamakura S, et al. Single nucleotide polymorphisms and haplotypes of CYP1A2 in a Japanese population. Drug Metab Pharmacokinet. 2005; 20: 24-33, CrossRef.

Aklillu E, Carrillo JA, Makonnen E, Hellman K, Pitarque M, Bertilsson L, et al. Genetic polymorphism of CYP1A2 in ethiophians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1. Mol Pharmacol. 2003; 64: 659-69, CrossRef.

Kendler KS, Prescott CA. Caffeine intake, tolerance, and withdrawal in woman: a population-based twin study. Am J Psychiatry. 1999; 156: 223-8, CrossRef.

Rasmussen BB, Brix TH, Kyvik KO, Brosen K. The interindividual differences in the 3-demethylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors. Pharmacogenetics. 2002; 12: 473-8, PMID.

Sachse C, Brockmöller J, Bauer S, Roots I. Functional significance of a C->A polymorphism in introl 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol. 2003; 47: 445-9, CrossRef.

Tiwari AK, Deshpande SN, Lerer B, Nimgaokar VL, Thelma BK. Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: V. association of CYP1A2 1545 C>T polynorphism. Pharmacogenomics J. 2007; 7: 305-11, CrossRef.

Chida M, Yokoi T, Fukui T, Kinoshita M, Yokota J, Kamataki J. Detection of three genetic polymorphism in the 5’flanking region and intron 1 of human CYP1A2 in the Japanese population. Jpn J Cancer Res. 1999; 90: 899-902, CrossRef.

Nakajima M, Yokoi T, Mizutani M, Kinoshita M, Funayama M, Kamataki T. Genetic polimorphism in the 5’flanking region of human CYP1A2 gene: effect on the VYP inducibility in human. J Biochem. 1999; 125: 803-8, CrossRef.

Chen X, Wang L, Zhi, L, Zhou G, Wang H, Zhang X, et al. The G-113A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese population. Clin Pharmacol Ther. 2005; 78: 249-59, CrossRef.

Han XM, Chen XP, Wu QN, Jiang CH, Zhou HH. G-2964A and C734A genetic polymorphism in Chinese population. Acta Pharmacol. 2000; 21: 1031-4, PMID.

Han X, Ouyang D, Chen X, Shu Y, Jiang C, Tan Z, et al. Inducibility of CYP1A2 by omeprazole in vivo related to the genetic polymorphism of CYP1A2. Br J Clin Pharmacol. 2002; 54: 540-3, CrossRef.

Quattrochi LC, Vu T, Tukey RH. The human CYP1A2 gene and induction by 3-methylcholanthrene: a region of DNA that support AH-receptors binding and promoter-specific induction. J Biol Chem. 1994; 269: 6949-54, PMID.

Djordjevic N, Ghotbi R, Bertilsson L, Jankovic S, Aklillu E. Induction of CYP1A2 by heavy coffee consumption in Serbs and Swedes. Eur J Clin Pharmacol. 2008; 64: 381-5, CrossRef.

Pesce AJ, Rashkin M, Kotagal U. Standard of laboratory practice: theophylline and caffeine monitoring. Clin Chem. 1988; 44: 1126-8, PMID.

Lane JD, Pieper CF, Phillips-Bute BG, Bryan JE, Kuhn CM. Caffeine affects cardiovascular and neuroendocrine activation at work and home. Psychosom Med. 2002; 64: 595-603, CrossRef.

Robertson D, Wade D, Workman R, Woosley RL, Oates JA. Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Inves. 1998; 67: 1111-7, CrossRef.

Olthof MR, Hollman PC, Katan MB. Chlorogenic acid and caffeic acid are absorbed in humans. J Nutr. 2001; 131: 66-71, CrossRef.

Andersen LF, Jacobs DR, Carlsen MH, Blomhoff R. Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular disease in the Iowa woman’s health study. Am J Clin Nutr. 2006; 83: 1039-46, CrossRef.

Papamichael CM, Aznaouridis KA, Karatzis EN, Karatzi KN, Stamatelopoulos KS, Vamvakou G, et al. Effect of coffee on endothelial function in healthy subjects: the role of caffeine. Clin Sci. 2005; 106: 55-60, CrossRef.

Mayorov DN. Does coffee reinforce the vascular inflammatory response to mental stress? J Hypertens. 2006; 24: 2149-51, CrossRef.

Kalow W, Tang BK. Caffeine as a metabolic probe: exploration of the enzyme-inducing effect of cigarette smoking. Clin Pharmacol Ther. 1991; 49: 44-8, CrossRef.




DOI: https://doi.org/10.18585/inabj.v10i3.374

Indexed by:

                 

                  

               

     

 

The Prodia Education and Research Institute